Explore Our Network

4TEEN4 Pharmaceuticals GmbH is a German biotech company pioneering precision medicine in critical care, with a mission to develop causal therapies for acute cardiovascular complications, particularly shock. The company focuses on targeting cDPP3, a key mediator in circulatory failure, and is advancing Procizumab, a first-in-class antibody, through clinical development. With a leadership team boasting over 150 years of pharma experience and a strong network of international researchers, 4TEEN4 aims to address unmet medical needs and improve patient outcomes where current therapies are inadequate.

A-G Associates is a Service-Disabled Veteran-Owned and SBA 8(a) organizational consulting firm that specializes in high-impact strategy and implementation, data analysis and visualization, stakeholder engagement, and change management solutions. The company is dedicated to helping mission-driven organizations across federal, non-profit, and private sectors navigate meaningful process, culture, and strategic transformation for measurable impact. A-G Associates is recognized for its innovative approach and commitment to excellence, as evidenced by its inclusion in the Inc. 5000 list of fastest-growing private companies in America.

AbViro is a Phase 2 clinical stage biotech company developing monoclonal antibody therapeutics for infectious diseases.

AccelerMED is dedicated to accelerating the adoption of innovative medical devices that enhance the quality and efficiency of patient care. With a focus on early-stage medical device companies, they provide commercial leadership and market development strategies to ensure successful commercialization and widespread adoption of novel technologies.

Accenture is a global professional services company with extensive capabilities in strategy and consulting, digital transformation, technology, and operations. The company aims to drive innovation and efficiency across various industries, helping clients navigate complex challenges and seize opportunities in a rapidly changing environment. Accenture is committed to creating positive change around the world and ensuring responsible business leadership for its people, clients, and communities. The company emphasizes continuous learning, responsible AI practices, and a culture of belonging and diversity.

Action Medical Technologies is a pharmaceutical and medical device company focused on developing innovative solutions that integrate medications with advanced devices and injector systems to improve patient outcomes, particularly in austere prehospital environments.

Adipothera develops therapies that repair damaged tissue rather than manage symptoms. We target the stromal microenvironment to address the underlying biology of fibrosis and tissue remodeling. Our lead program addresses radiation-induced skin injury across both medical countermeasure and oncology supportive care settings, with an expanding pipeline in lymphedema and pathological bone formation.

AdraCard develops a proprietary drug delivery solution aimed at preventing hospitalizations and deaths from anaphylaxis by integrating adrenaline administration into everyday life. The company's mission is to address limitations of current adrenaline delivery methods, such as bulkiness, short shelf life, susceptibility to temperature, needle phobia, and low compliance. AdraCard's approach centers on accessibility, ease of use, and safety, underpinned by a team with extensive experience in drug-device development.

ADS, Inc. (Atlantic Diving Supply) is a leading value-added logistics and supply chain solutions provider serving all branches of the U.S. Military, federal, state and local government organizations, law enforcement agencies, first responders, partner nations, and the defense industry. Founded in 1997 in Virginia Beach, VA, ADS has grown into a Top 50 Department of Defense Contractor, recognized for its commitment to legendary customer service, broad procurement options, and innovative product and service offerings. The company is deeply rooted in its community, supporting military families, veterans, and first responders through scholarships, corporate giving, and ongoing service. ADS upholds the highest standards of business ethics, compliance, and quality, as demonstrated by its AS9100D, ISO 9001:2015, and ISO 14001:2015 certifications.

Advanced Functional Fabrics of America (AFFOA) is a nonprofit, public-private partnership and a U.S. Department of Defense-funded Manufacturing USA Innovation Institute. AFFOA is dedicated to revitalizing the U.S. textile industry by transforming traditional fibers, yarns, and textiles into sophisticated, integrated, and networked devices and systems. The organization aims to bridge the gap between early-stage technology and commercialization, leveraging its expertise and membership ecosystem to advance textile-based products with transformative capabilities for defense and consumer markets.

Advanced Light Devices manufactures the patent pending Hemealumen Polychromatic Device Innovative Solutions for Treating Infectious and Neurodegenerative Diseases Company Overview Advanced Light Devices is a pioneering company established in the early 2000s, dedicated to developing advanced medical technologies for the treatment of a range of diseases. With a vision to revolutionize healthcare, the company focuses on innovative therapies that utilize light-based technology to address complex medical challenges. The Hemealumen Polychromatic Device At the core of Advanced Light Devices' portfolio is the Hemealumen Polychromatic Device, a state-of-the-art medical tool designed to combat both viral and bacterial diseases. In addition, this device is being used as a therapeutic option for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease. Applications in Infectious Disease Treatment The Hemealumen Polychromatic Device has demonstrated effectiveness in treating a variety of infectious diseases, including: Malaria Dengue fever COVID-19 Zika virus Shingles By utilizing targeted polychromatic light, the device disrupts the replication and survival mechanisms of pathogens, offering a non-invasive and innovative approach to disease management. Blood Treatment During Transfusions The Hemealumen Polychromatic Device is also used to treat blood during transfusions, effectively eliminating bacteria and viruses. This process enhances the safety of blood transfusions, reducing the risk of transfusion-transmitted infections and improving patient outcomes. Impact on Neurodegenerative Diseases Beyond infectious diseases, the device shows promise in the management of neurodegenerative conditions such as ALS and Parkinson's disease. Its mechanism of action may help reduce the progression of these disorders, though further research is ongoing to fully understand its therapeutic potential. Conclusion Advanced Light Devices, through the Hemealumen Polychromatic Device, is at the forefront of medical innovation. Their commitment to developing effective treatments for both infectious and neurodegenerative diseases position them as a leader in the field of light-based medical technology.

Advanced Material Development Inc. is a US-headquartered global defense technology company specializing in nanomaterial-based solutions for stealth, shielding, and sensing in defense and aerospace applications. The company focuses on engineering lightweight, scalable, and sustainable materials that deliver operational advantages for military and security sectors. With collaborative R&D partnerships involving leading universities and industry, it brings innovations in radar absorption, EMI shielding, laser defense, and chemical sensing platforms. The company operates in the United States and United Kingdom, maintaining strong compliance, environmental, and security standards.

Advanced Materials and Devices, Inc. (AMAD) is a leader in the development of wearable blast sensors and controllable vehicle suspension technologies. The company is dedicated to advancing safety and protection through innovative solutions, particularly in the field of blast measurement and safety technology. AMAD's mission is to lead advancements in these areas, providing state-of-the-art solutions for both military and commercial applications.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Aegilys specializes in the development of advanced electrochemical sensors for real-time chemical and biological threat detection as well as physiological monitoring. Integrating cutting-edge materials science, nano-engineering, and edge analytics, the company supports operational readiness, safety, and performance for defense, security, and elite athletic markets. Headquartered in Rockville, Maryland, Aegilys is recognized for its multidisciplinary expertise and innovation in sensor technology for demanding environments.

AeroVironment designs, develops, and deploys uncrewed aerial, ground, and loitering munitions systems, as well as advanced autonomy and mission software for defense, security, and exploration applications. The company has a track record of pioneering innovations in robotics, high-altitude platforms, and planetary flight systems, delivering scalable and adaptable technologies for complex and demanding missions across multiple domains.

AiRANACULUS is a leader in Intelligent RF and Networking Solutions, providing advanced technologies for applications from Space to Smart Cities. The company focuses on creating spectrum-aware technologies that optimize radio and sensor systems for performance in complex environments, leveraging expertise in signal processing, cybersecurity, and networking.

Airion Health LLC is dedicated to transforming innovative concepts into operational defense solutions with accelerated timelines. The company focuses on developing technology that enhances the capabilities of the United States and its allies, prioritizing innovative products over traditional processes to address rapidly advancing threats. Airion positions itself at the intersection of innovation and precision, leveraging extensive expertise in design, advanced manufacturing, and global distribution to tackle challenges faced by the US Armed Forces and the private sector.

Akthelia Pharmaceuticals is a pioneering biopharmaceutical company focused on developing therapeutics that enhance the body's innate defense mechanisms to combat debilitating diseases. The company targets mucosal barrier injury and epithelial integrity through a novel immunotherapeutic strategy. Its mission is to revolutionize treatment for diseases such as cancer, infection, and autoimmune disorders by leveraging the body's own microbial defense mechanisms.

Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.

Alithia Life Sciences is an Australian-owned, boutique, full-service Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, device companies, and institutional research groups with their projects in Australia and beyond. With over 25 years of operational expertise across a wide range of therapeutic areas, Alithia offers personalized project management from Phase I to Phase III, aiming to deliver efficient project outcomes, add value to client programs, and ultimately improve human health and wellbeing.